Patent · US Expired

Modulators of angiogenesis

US7485414B2 · kind B2 · utility

3Cited by
0References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 30, 2002
Grant dateFeb 3, 2009
Priority date
Expiry dateAug 30, 2022

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention relates to regulation of angiogenesis. More particularly, the present invention is directed to nucleic acids encoding “angiogenesis regulatory proteins and nucleic acids” which are involved in modulation of angiogenesis. The invention further relates to methods for identifying and using agents, including small organic molecules, antibodies, peptides, cyclic peptides, nucleic acids, antisense nucleic acids, RNAi, and ribozymes, that modulate angiogenesis via modulation of angiogenesis regulatory proteins and nucleic acids; as well as to the use of expression profiles and compositions in diagnosis and therapy of diseases related to angiogenesis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.